Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective StudyS. Hescot, Sophie Leboulleux, Bruna Calsina et al.|The Journal of Clinical Endocrinology & Metabolism|2019Cited by 180
Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or PheochromocytomaAlexandre Buffet, Laurène Ben Aim, Sophie Leboulleux et al.|The Journal of Clinical Endocrinology & Metabolism|2019Cited by 124
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trialÉric Baudin, Anouk van Berkel, Bernard Goichot et al.|The Lancet|2024Cited by 69
Recurrence-Free Survival Analysis in Locally Advanced Pheochromocytoma: First AppraisalSophie Moog, Éric Baudin, Frédéric Castinetti et al.|The Journal of Clinical Endocrinology & Metabolism|2021Cited by 16
Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytomaAlexandre Buffet, Anne‐Paule Gimenez‐Roqueplo, Laurène Ben Aim et al.|Endocrine Abstracts|2019Cited by 1